logo-loader
CSE:PILL OTCQB:CTABF

Canntab Therapeutics Ltd

Receive alerts
Market:
CSE
Price
0.0050 CAD
Day Change
-
Market Cap:
$389.09 k
52 weeks high
0.02
52 weeks low
0.0050

In brief

Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Long referred to as Cannabis 3.0 by the company, Canntab’s proprietary hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in pharmacies around the world. These will include the following formulations: once a day and extended release, both providing an accurate dose and improved shelf stability.